Page URL: https://www.bionews.org.uk/page_89688

Safety fears over ES cells allayed

6 June 2005
By BioNews
Appeared in BioNews 311

Human embryonic stem cells (ES cells) do not show signs of genetic instability when grown for extended periods in the laboratory, UK researchers say. The results, published in the journal Nature Genetics, are 'not only surprising but good news for potential therapeutic use', says study leader Roger Pederson. The scientists, based at the University of Cambridge, have shown that the process of 'genetic imprinting' - the 'tagging' of certain genes, which marks them as either maternal or paternal in origin - does not appear to be disrupted in ES cells grown in culture.

For most genes in the developing mammalian embryo, both the maternal and paternal copies are either switched on or off in a particular tissue at any given point. But for a small number of 'imprinted' genes, only the copy from one parent is switched on, whilst the other remains inactive - a process crucial to normal development. Previous research carried out on mouse ES cells has detected changes in genetic imprinting, when the cells are grown in the laboratory, and scientists feared that the same might be true of human ES cells. However, the latest study suggests this is not the case, paving the way for new therapies based on these cells.

The scientists studied six of the 75 genes known to be imprinted in humans, in four different ES cell lines, and found that all had remained stable. 'The remarkable consistency we found between four lines and with respect to six genes suggests the stability is a property of human ES Cells, not just a property of these lines or genes', said Pederson. Had the cells not appeared to be so stable, then far more work would have been necessary to ensure their safety, he added. UK developmental biologist Robin Lovell-Badge agreed that it was 'very important' for the human stem cell field to have this stability demonstrated. However, more work into the safety of ES cells still needs to be done, say experts.

Many researchers hope that research into ES cells, the body's 'master cells' that can grow into almost any type of body cell, will yield new treatments for a range of disorders. 'As an advocate myself of the therapeutic use of these cells, I couldn't sleep at night if I hadn't done this study', said Pederson. The stem cell scientist, who moved from the US to the UK to carry out his research, said the intellectual climate for researchers working in this field in Britain was 'unequalled', but that more investment was urgently needed to take the work forward.

SOURCES & REFERENCES
Embryonic stem cells pass key safety test
New Scientist |  31 May 2005
Research boosts hope for stem cell therapy
The Guardian |  1 June 2005
Scientists Clear Major Hurdle in Stem Cell Research
The Scotsman |  31 May 2005
Study calms fears over stem cells
BBC News Online |  31 May 2005
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
8 September 2005 - by BioNews 
Human embryonic stem (ES) cells grown for a long time in the laboratory become genetically unstable, according to a new study by an international group of researchers. The scientists, who published their findings in the journal Nature Genetics, say that many of the older cell lines they studied had acquired...
26 May 2005 - by BioNews 
The US House of Representatives has approved a bill that would overturn President Bush's current policy on human embryonic stem (ES) cell research. Members of the House voted 238-194 in favour of the Stem Cell Research Enhancement Act of 2005, which was sponsored by Michael Castle and Dianne DeGette...
23 May 2005 - by BioNews 
Appropriate safety systems must be in place before embryo stem cell therapies are used to treat patients, according to an editorial published in the British Medical Journal last week. The article says that although many more human embryonic stem (ES) cell lines are now available, much more work needs to...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.